![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/26/2904406/0/en/Intellia-Therapeutics-Announces-CFO-Transition.html
https://www.fiercebiotech.com/biotech/intellia-doesnt-need-re-dose-gene-edited-ntla-2001-new-data-shows-it-can-be-done
https://www.globenewswire.com/news-release/2024/06/25/2904115/0/en/Intellia-Announces-Positive-Clinical-Proof-of-Concept-Data-for-Redosing-a-CRISPR-Based-Therapy-with-its-Proprietary-LNP-Based-Delivery-Platform.html
https://www.globenewswire.com/news-release/2024/06/17/2899558/0/en/Intellia-Therapeutics-to-Present-the-First-Ever-Clinical-Data-From-Patients-Redosed-with-an-Investigational-In-Vivo-CRISPR-Gene-Editing-Therapy-at-the-Peripheral-Nerve-Society-Annu.html
https://www.globenewswire.com/news-release/2024/06/14/2898922/0/en/Intellia-Therapeutics-Names-Brian-Goff-to-its-Board-of-Directors.html
https://ir.intelliatx.com/news-releases/news-release-details/intellia-therapeutics-announces-positive-long-term-data-ongoing
https://www.globenewswire.com/news-release/2024/06/02/2891838/0/en/Intellia-Therapeutics-Announces-Positive-Long-Term-Data-from-Ongoing-Phase-1-Study-of-NTLA-2002-an-Investigational-In-Vivo-CRISPR-Gene-Editing-Treatment-for-Hereditary-Angioedema-H.html
https://www.globenewswire.com/news-release/2024/05/09/2878654/0/en/Intellia-Therapeutics-Announces-First-Quarter-2024-Financial-Results-and-Highlights-Recent-Company-Progress.html
https://www.globenewswire.com/news-release/2024/05/02/2874072/0/en/Intellia-Therapeutics-to-Hold-Conference-Call-to-Discuss-First-Quarter-2024-Earnings-and-Company-Updates.html
https://www.globenewswire.com/news-release/2024/04/29/2871132/0/en/Intellia-Therapeutics-to-Present-Updated-Data-from-Phase-1-2-Study-of-NTLA-2002-for-the-Treatment-of-Hereditary-Angioedema-HAE-at-the-EAACI-Congress-2024.html